Evotec SE (Nasdaq:EVO), the German biotechnology company, recently succumbed to a cyberattack. Its Nasdaq shares appeared to be unaffected by the revelation, which described a IT network intrusion occurring on April 6. In a communiqué, the company said it preemptively shut down its IT systems as a result of the attack, disconnecting them from the…
Exploring the potential of Web3-based carbon tracking in pharma
Carbon tracking is a challenge in many industries, including the pharma sector. Companies are looking to manage their carbon emissions more effectively and meet their environmental, social and governance (ESG) goals, noted Maxence Cacheux, Zblocks co-founder and chief revenue officer. “They need to measure their internal carbon emissions (Scope 1), indirect emissions from the energy…
2023 State of Revenue Report highlights staffing challenges for pharma companies
The software company Model N (NYSE:MODN) has released its fifth annual State of Revenue report that found many pharma companies are grappling with staffing and economic challenges. In particular, 92% of pharmaceutical firms reported difficulties hiring qualified personnel. A number of pharma companies are cutting staff this year. Almost half, 47%, of pharma execs believed…
For the sake of sustainability, put people at your core
It’s no secret the pharmaceutical industry has been slow to adopt sustainability practices. Unlike other industries, end users haven’t demanded products be made “greener.” In manufacturing, sustainability is still considered a cost rather than an investment. New technologies and innovative solutions may promise to deliver results, but many take years to show any return. In…
Why Servblock is still banking on blockchain for pharma and biotech
In recent years, interest in blockchain distributed ledger technology has crescendoed and crashed. Boosters of the technology proclaimed that it could revolutionize everything from the pharma supply chain to business contracts. However, critics lamented that the technology often appeared like an expensive solution in search of a problem. “There’s been a lot of false promises…
AmpleLogic embraces low-code approach to help pharma companies digitally transform
Many pharmaceutical companies have recently ramped up their focus on digital transformation. But in the highly regulated pharma industry, digital transformation programs can be slow and expensive. Hyderabad, India–based AmpleLogic works with pharma companies to launch and scale digital transformation initiatives via its low-code platform, which can standardize and accelerate innovation in the industry, according…
Emerson debuts software for CIP applications
Emerson (NYSE:EMR) has launched its new Clean In Place (CIP) Utilities and Automated Reporting Analytics package on its PACEdge and Movicon platforms on an industrial edge control device. The food and beverage, and pharmaceutical industries use the clean- and steam-in-place method to clean fittings, vessels, filters, pipes and other internal surfaces without disassembly. Emerson notes that Steam In Place (SIP) has a more…
Eschbach debuts Shiftconnector’s AI-based smart search to optimize plant performance
The software developer Eschbach has added AI-based search engine capabilities to its Shiftconnector digital manufacturing software for process manufacturing. The company specializes in serving the needs of the pharmaceutical and chemical industries. Eschbach introduced its Shiftconnector software almost two decades ago to facilitate handover, employee communication, production management and regulatory compliance. The new Smart Search functionality in the Shiftconnector…
KUKA to highlight robotic automation at ACTE 2022 in Las Vegas
KUKA Robotics (Shelby Township, Michigan) will share advice on how to find and train skilled workers at the Association for Career & Technical Education (ACTE) CareerTech VISION 2022 conference at the Las Vegas Convention Center. The event is scheduled for November 30 to December 3. The company’s robots are used in a range of industries,…
Why digital technologies are seeing lift-off in pharma
The pharma industry has been slower to adopt digital technologies than other less-regulated sectors. But many pharmaceutical companies making aggressive digital investments are beginning to see a payoff. Though comprehensive digital-based programs can cost roughly $50 million to $100 million annually for two to three years, according to McKinsey, they can lead to improved quality, increased…